Innovate UK is a government-backed agency supporting business-led innovation across the United Kingdom.
SFC Capital led the equity portion of the pre-seed round, which also included a grant from Innovate UK.
"In my last company, we spoke with literally thousands of producers, financiers, distributors and brands. All of them faced the same issue, knowing what they should be creating, selling or buying, as well as how it should be positioned, what were the target markets and what audiences truly wanted. That is what North AI is here to solve"
.png)
Innovate UK has backed the female-led health startup to expand representation in clinical trials.
"SökerData’s mission is to use data to develop insights that increase efficiency, safety and equity in drug discovery and regulatory reporting. We have high hopes that SökerData will play a pivotal role in changing the way that we research, develop and administer treatments for disease including cancer.."
The funding round was co-led by DSW Ventures and NG Bio alongside a grant from Innovate UK.
"We have been developing this method of treatment for a decade now, with support from Versus Arthritis, and it has proved successful in laboratory tests, but the funding will allow us to move toward human clinical trials."
SFC Capital led the pre-seed round, which will help Furbnow expand its supplier network for home energy upgrades.
"Everyone deserves a warm, comfortable home without costly bills and yet 11.7 million homes sit at the D energy rating or less. Sadly, energy efficiency has been the poor relation to the low-carbon technologies that grab headlines. But if your home is cold and draughty, no amount of Co2 savings is going to be better for you. We’re building Furbnow to be the go-to platform for homeowners who want advice and support as they plan and install low carbon technologies and energy efficiency elements in homes,"
The funding round includes a grant from Innovate UK and strategic backing from Modality Partnership to develop hypertension and mental health services.
"Over 30% of hypertension patients are affected by anxiety or depression, impacting their ability to manage lifestyle behaviours consistently. At Holly Health, we have supported over 30,000 people so far and are committed to innovating to solve our biggest human and healthcare challenges. This funding marks a pivotal moment – with the support of Innovate UK and the strategic investment from Modality Partnership, we are empowered to combat the complex and unresolved challenge of multimorbidity."
